NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo
Specialty pharmaceutical firm for rare diseases and unmet medical needs.
Türkiye
GENIL
Genmab Logo
Creates and develops antibody therapeutics for cancer and other serious diseases.
Denmark
GMAB
GENOLUTION INC. Logo
Develops molecular diagnostics and RNA interference solutions for research and IVD.
South Korea
225220
Genome&Company Logo
Develops microbiome drugs and novel immune checkpoint inhibitors for immuno-oncology.
South Korea
314130
Genomtec S.A. Logo
Develops mobile platforms for rapid, point-of-care molecular diagnostics.
Poland
GMT
GENOTECH CORP. Logo
Provides products and services for molecular biology research.
South Korea
066830
GenSight Biologics S.A. Logo
Develops gene therapies for neurodegenerative retinal and central nervous system diseases.
France
SIGHT
Gentian Diagnostics ASA Logo
Develops and markets in vitro diagnostic reagents for human and veterinary use.
Norway
GENT
GERON CORP Logo
A biopharma company developing a telomerase inhibitor for hematologic malignancies.
United States of America
GERN
GILEAD SCIENCES, INC. Logo
A research-based biopharmaceutical company focused on virology, oncology & inflammation.
United States of America
GILD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.